2BBBullish & Bearish
Health Care

Twist Bioscience Corporation (TWST) Stock Score & Signals

Twist Bioscience Corporation (TWST) trades on NASDAQ. It operates in the Health Care sector, Diagnostics & Research industry. Its current 2BB score is 47 out of 100.

About Twist Bioscience Corporation

Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck. The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox. In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design.

2BB score and signals

Twist Bioscience Corporation’s current 2BB score is 47 out of 100, built from the signal categories below.

SignalScoreReading
Activity71High
Momentum50Stable
Financial strength39Weak
Quality100Very Strong
Risk39Low

Company facts

CEOEmily LeProust
Founded2013
Employees979
52-week range$23.30 – $155.44

Recent earnings

Report dateEPS actualEPS estimateRevenue actualRevenue estimate
2027-02-01-0.4116$126.93M
2026-11-12-0.3898$124.80M
2026-08-03-0.56-0.5036$118.38M$116.78M
2026-05-04-0.59-0.4869$110.72M$109.81M